Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Eddy Bover"'
Autor:
Marisela Fátima Suárez Pedroso, Yusmel Sordo Puga, Danny Pérez Pérez, María Pilar Rodríguez Moltó, Iliana Sosa Testé, Aymé Oliva Cárdenas, Carlos Antonio Duarte Cano, Elaine Santana Rodríguez, Paula Naranjo Valdéz, Nemecio González Fernández, Milagros de la Caridad Vargas Hernández, Talía Sardina González, Mary Karla Méndez Orta, Yaneris Cabrera Otaño, Julio Ancizar Fragoso, Fé Fernández Zamora, Carlos Montero Espinosa, Avelina León Goñi, Yoandy Fuentes Rodríguez, Eddy Bover Fuentes, María Teresa Frías Laporeau, Mario Pablo Estrada García
Publikováno v:
Anales de la Academia de Ciencias de Cuba, Vol 12, Iss 3 (2022)
Introducción. Porvac es una vacuna de subunidad contra la peste porcina clásica, cuyo principio activo es la proteína quimérica entre el antígeno E2 y el adyuvante mo- lecular CD154. Se ha demostrado su capacidad para evitar la transmisión
Externí odkaz:
https://doaj.org/article/44514e1766694054bd25764a52474ddf
Autor:
Dayana Morales-Borrell, Nemecio González-Fernández, Néstor Mora-González, Carlos Pérez-Heredia, Ana Campal-Espinosa, Eddy Bover-Fuentes, Eladio Salazar-Gómez, Yissel Morales-Espinosa
Publikováno v:
AMB Express, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract Culture medium composition is one of the most important parameters to analyze in biotechnological processes with industrial purposes. The aim of this study was to design of a culture medium for optimal growth of the bacterium Pseudoxanthomon
Externí odkaz:
https://doaj.org/article/385f0f205dae4b56a74f46a77899c920
Autor:
Roberto Basulto Baker, Gerardo Guillén Nieto, Lesvia Calzada Aguilera, Jesús Junco Barranco, Nelson Izquierdo Pérez, Osvaldo Reyes Acosta, Hilda Garay Pérez, Ricardo Bringas Pérez, Eulogio Pimentel Vázquez, José A. Bertot, Rafael Avilés, María Dolores Castro Santana, Eddy Bover Fuentes, Franklin Fuentes Aguilar
Publikováno v:
Revista de Producción Animal, Vol 30, Iss 3, Pp 49-57 (2018)
This paper describes for the first time the generation of the K88ab-GnRH hybrid fimbria, the fusion of N. meningitidis P64k protein (P64k-GnRH), and its evaluation as vaccine candidates to control fertility in mammals. Twenty hybrid male pigs were ra
Externí odkaz:
https://doaj.org/article/a1e9f06e3b3941e381712971afebd2dd
Autor:
Roberto Basulto Baker, Gerardo Guillén Nieto, Lesvia Calzada Aguilera, Jesús Junco Barranco, Nelson Izquierdo Pérez, Osvaldo Reyes Acosta, Hilda Garay Pérez, Ricardo Bringas Pérez, Eulogio Pimentel Vázquez, José A. Bertot, Rafael Avilés, María Dolores Castro Santana, Eddy Bover Fuentes, Franklin Fuentes Aguilar
Publikováno v:
Revista de Producción Animal, Vol 30, Iss 3, Pp 1-9 (2018)
Externí odkaz:
https://doaj.org/article/a8ae49aa82eb462993f4f78ddb77cf56
Autor:
Jesús A. Junco, Ranfis Rodríguez, Franklin Fuentes, Idania Baladrón, Maria D. Castro, Lesvia Calzada, Carmen Valenzuela, Eddy Bover, Eulogio Pimentel, Roberto Basulto, Niurka Arteaga, Angel Cid-Arregui, Francisco Sariol, Lourdes González, Liliana Porres-Fong, María Medina, Ayni Rodríguez, A. Hilda Garay, Osvaldo Reyes, Matilde López, Lourdes de Quesada, Allelin Alvarez, Carolina Martínez, Marleny Marrero, Guillermo Molero, Alfredo Guerra, Pedro Rosales, Carlos Capote, Sahily Acosta, Idania Vela, Lina Arzuaga, Ana Campal, Erlán Ruiz, Elier Rubio, Pável Cedeño, María Carmen Sánchez, Pedro Cardoso, Rolando Morán, Yairis Fernández, Magalys Campos, Henio Touduri, Dania Bacardi, Indalecio Feria, Amilcar Ramirez, Karelia Cosme, Pedro López Saura, Maricel Quintana, Verena Muzio, Ricardo Bringas, Marta Ayala, Mario Mendoza, Luis E. Fernández, Adriana Carr, Luis Herrera, Gerardo Guillén
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Heberprovac is a GnRH based vaccine candidate containing 2.4 mg of the GnRHm1-TT peptide as the main active principle; 245 μg of the very small size proteoliposomes adjuvant (VSSP); and 350 μL of Montanide ISA 51 VG oil adjuvant. The aim of this st
Externí odkaz:
https://doaj.org/article/7fa9e2020e7f4dcf9cc2aaa835127a26
Autor:
Marisela Suárez-Pedroso, Yusmel Sordo-Puga, María Pilar Rodríguez-Moltó, Paula Naranjo-Valdés, Danny Pérez-Pérez, Iliana Sosa-Teste, Carlos Montero-Espinosa, Yohandy Fuentes-Rodríguez, Talía Sardina-González, Elaine Santana-Rodríguez, Milagros Vargas-Hernández, Ayme Oliva-Cárdenas, Nemecio González-Fernández, Eddy Bover-Fuentes, Carlos A. Duarte, Mario Pablo Estrada-García
Publikováno v:
Bionatura. 8:1-7
Porvac is a classical swine fever (CSF) subunit vaccine. It is safe and induces a robust neutralizing antibody response, sterilizing immunity, and early protection, and it prevents vertical transmission in pregnant sows. The methodology to approve Po
Autor:
Angel Cid-Arregui, Osvaldo Reyes, Gisell Bebert, Niurka Arteaga, Franklin Fuentes, Lesvia Calzada, Ana C. Campal, Eulogio Pimentel, Raúl González, Yovisleidis López, Rafael Chacon Ruiz Martinez, Matilde López, Jesús A. Junco, Roberto Basulto, Gerardo Guillén, Andrés Serradelo, Eddy Bover, Mirialis Arias, Maria D. Castro, Eduardo Guerra Hernández, A. Rodríguez, Hilda Garay
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Background: Vaccines based on modified GnRH peptide variants can be an alternative treatment for advanced prostate cancer. However, the efficacy of the GnRH-based vaccine variants has been limited by their insufficient immunogenicity. Methods: The cu
Autor:
Yohandy Fuentes-Rodríguez, María Pilar Rodríguez-Moltó, Yusmel Sordo-Puga, Talía Sardina-González, Nemecio González-Fernández, Milagros Vargas-Hernández, Mario Pablo Estrada-García, Maria Teresa Frías-Laporeaux, Iliana Sosa-Teste, Danny Pérez-Pérez, Paula Naranjo-Valdés, Carmen Laura Pereda, Elaine Santana-Rodríguez, Eddy Bover-Fuentes, Aymé Oliva-Cárdenas, Marisela Suárez-Pedroso, Carlos Montero-Espinosa, Carlos Duarte
Publikováno v:
Veterinary immunology and immunopathology. 234
E2CD154 is a vaccine candidate against classical swine fever (CSF) based on a chimeric protein composed of the E2 glycoprotein fused to porcine CD154 antigen, and formulated in the oil adjuvant Montanide™ ISA 50 V2. This vaccine confers early prote
Autor:
Jesús A. Junco, Ranfis Rodríguez, Franklin Fuentes, Idania Baladrón, Maria D. Castro, Lesvia Calzada, Carmen Valenzuela, Eddy Bover, Eulogio Pimentel, Roberto Basulto, Niurka Arteaga, Angel Cid-Arregui, Francisco Sariol, Lourdes González, Liliana Porres-Fong, María Medina, Ayni Rodríguez, A. Hilda Garay, Osvaldo Reyes, Matilde López, Lourdes de Quesada, Allelin Alvarez, Carolina Martínez, Marleny Marrero, Guillermo Molero, Alfredo Guerra, Pedro Rosales, Carlos Capote, Sahily Acosta, Idania Vela, Lina Arzuaga, Ana Campal, Erlán Ruiz, Elier Rubio, Pável Cedeño, María Carmen Sánchez, Pedro Cardoso, Rolando Morán, Yairis Fernández, Magalys Campos, Henio Touduri, Dania Bacardi, Indalecio Feria, Amilcar Ramirez, Karelia Cosme, Pedro López Saura, Maricel Quintana, Verena Muzio, Ricardo Bringas, Marta Ayala, Mario Mendoza, Luis E. Fernández, Adriana Carr, Luis Herrera, Gerardo Guillén
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
Heberprovac is a GnRH based vaccine candidate containing 2.4 mg of the GnRHm1-TT peptide as the main active principle; 245 μg of the very small size proteoliposomes adjuvant (VSSP); and 350 μL of Montanide ISA 51 VG oil adjuvant. The aim of this st
Autor:
Franklin Fuentes, Aguilar, Jesús Junco, Barranco, Lesvia Calzada, Aguilera, Eddy Bover, Fuentes, Jose André, Serradelo Leal, Eduardo Hernández, López, Eulogio Pimentel, Vázquez, Roberto Basulto, Baker, Osvaldo Reyes, Acosta, Hilda Garay, Pérez, Gerardo Guillén, Nieto
Publikováno v:
Journal of experimental therapeuticsoncology. 12(2)
Therapeutic vaccines, specifically the Gonadotrophin Releasing Hormone (GnRH) vaccine, are considered an additional therapeutic option for advanced stage prostate cancer. Our work showed amplification of the immune response when combining two peptide